Globe Life (NYSE:GL) Sets New 52-Week High – Here’s What Happened

Globe Life Inc. (NYSE:GL)’s stock price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $163.50 and last traded at $162.9420, with a volume of 449020 shares trading hands. The stock had previously closed at $159.33.

Analyst Ratings Changes

GL has been the subject of several analyst reports. Wells Fargo & Company raised their price objective on Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. Truist Financial raised their price objective on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Piper Sandler raised their price objective on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Finally, Evercore set a $157.00 price objective on Globe Life in a research note on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Globe Life has an average rating of “Moderate Buy” and an average price target of $174.11.

Globe Life Price Performance

The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $12.95 billion, a P/E ratio of 11.53 and a beta of 0.49. The stock has a 50 day moving average of $152.88 and a 200-day moving average of $144.52.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the business posted $3.07 earnings per share. Globe Life’s revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities research analysts anticipate that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Insiders Place Their Bets

In related news, CFO Thomas Peter Kalmbach sold 7,936 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the completion of the sale, the chief financial officer directly owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This trade represents a 13.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at $8,463,853.60. This represents a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 105,929 shares of company stock valued at $16,382,450 over the last quarter. 2.11% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Globe Life

Institutional investors and hedge funds have recently modified their holdings of the business. Compound Planning Inc. raised its position in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after purchasing an additional 82 shares in the last quarter. Root Financial Partners LLC raised its position in Globe Life by 23.3% during the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after purchasing an additional 83 shares in the last quarter. Transcend Capital Advisors LLC raised its position in Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after purchasing an additional 84 shares in the last quarter. Natural Investments LLC raised its position in Globe Life by 2.6% during the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC raised its position in Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after purchasing an additional 87 shares in the last quarter. 81.61% of the stock is owned by institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.